Literature DB >> 33830371

Ophthalmic manifestations in patients with collagen vascular disorders: a hospital-based retrospective observational study.

Surinder Kumar Sharma1, Anju Lath Sharma2, Vikram K Mahajan3.   

Abstract

AIM: To study frequency and characteristics of ocular manifestations in Indian patients with collagen vascular disorders.
METHODS: The medical records of 73 patients (Males: Females 16:57) aged between 22 and 78 years (mean ± SD = 43.5 ± 12.9 years) with collagen vascular diseases were analyzed retrospectively for demography, subtypes of collagen vascular disease, and findings of complete ophthalmic examination.
RESULTS: Lupus erythematosus (LE) in 39(53.4%, (SLE 18, DLE 21), systemic sclerosis in 27(37%), dermatomyositis in 5(6.8%), and primary Sjögren's syndrome in 2(2.7%) patients, respectively, were observed. Only 35(47.9%) patients had ocular manifestations. In LE keratoconjunctivitis sicca (n = 6), keratitis (n = 5), severe blepharitis (n = 3), retinopathy (n = 2), and optic neuritis in one patient, respectively, were major ocular manifestations. Major abnormalities occurring in systemic sclerosis included restricted eyelid mobility of variable severity (n = 8), eyelid telangiectasia (n = 5), keratoconjunctivitis sicca (n = 6), cataract (n = 5), shallow fornices (n = 4), conjunctival surface disease (n = 4), and uveitis, keratitis, episcleritis in one patient each, respectively. One patient with dermatomyositis had heliotrope rash. Two patients with primary Sjögren's syndrome had keratoconjunctivitis sicca.
CONCLUSIONS: The study shows that LE frequently presented with keratoconjunctivitis sicca, retinopathy, and optic neuritis. Systemic sclerosis commonly develops eyelid immobility, blepharitis and telangiectasia, ocular surface disease and keratoconjunctivitis sicca, corneal abnormalities, and uveitis. A comprehensive ocular evaluation is imperative for early detection and management particularly of ocular surface disease, uveitis, and retinopathy to prevent potential sight-threatening complications. Limitations include retrospective study design and small number of patients for stratification.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Autoimmune disorders; Blepharitis; Dermatomyositis; Discoid lupus erythematosus; Keratopathy; Lupus erythematosus; Ocular abnormalities; Ocular surface disease; Retinopathy; Sjögren's syndrome; Systemic sclerosis; Uveitis

Mesh:

Substances:

Year:  2021        PMID: 33830371     DOI: 10.1007/s10792-021-01833-x

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  35 in total

Review 1.  Systemic and localized scleroderma.

Authors:  Lorinda Chung; Jan Lin; Daniel E Furst; David Fiorentino
Journal:  Clin Dermatol       Date:  2006 Sep-Oct       Impact factor: 3.541

Review 2.  Ocular manifestations of systemic lupus erythematosus.

Authors:  John B Davies; Prabakar Kumar Rao
Journal:  Curr Opin Ophthalmol       Date:  2008-11       Impact factor: 3.761

3.  Retinopathy in adult dermatomyositis.

Authors:  A Chu-Lee; G Stroller; I A Jaffe
Journal:  J Rheumatol       Date:  1995-12       Impact factor: 4.666

4.  Discoid lupus erythematosus presenting as asymmetric posterior blepharitis.

Authors:  P Gloor; M Kim; J M McNiff; D Wolfley
Journal:  Am J Ophthalmol       Date:  1997-11       Impact factor: 5.258

5.  Ocular involvement in a case of scleroderma.

Authors:  R Anand
Journal:  Indian J Ophthalmol       Date:  1985 Jan-Feb       Impact factor: 1.848

Review 6.  Dermatomyositis.

Authors:  Jeffrey P Callen; Robert L Wortmann
Journal:  Clin Dermatol       Date:  2006 Sep-Oct       Impact factor: 3.541

Review 7.  Lupus erythematosus: systemic and cutaneous manifestations.

Authors:  Naomi Rothfield; Richard D Sontheimer; Megan Bernstein
Journal:  Clin Dermatol       Date:  2006 Sep-Oct       Impact factor: 3.541

Review 8.  Ocular manifestations of scleroderma.

Authors:  Rajen Tailor; Abha Gupta; Ariane Herrick; Jeffrey Kwartz
Journal:  Surv Ophthalmol       Date:  2009 Mar-Apr       Impact factor: 6.048

9.  Atypical central retinal artery occlusion: an uncommon cause of retinopathy and visual loss in dermatomyositis.

Authors:  Mukta Sharma; Aditi Prashar; Rajiv Tuli; Rattan K Sharma; Vikram K Mahajan
Journal:  Int J Rheum Dis       Date:  2015-09-25       Impact factor: 2.454

10.  Severity of scleritis and episcleritis.

Authors:  M Sainz de la Maza; N S Jabbur; C S Foster
Journal:  Ophthalmology       Date:  1994-02       Impact factor: 12.079

View more
  2 in total

Review 1.  A meta-analysis of prognostic biomarkers in neonatal retinal hemorrhage.

Authors:  Yan Xu; Ying Wang; Shouqing Li
Journal:  Int Ophthalmol       Date:  2021-10-08       Impact factor: 2.031

2.  Assessment and Management of Dry Eye Disease and Meibomian Gland Dysfunction: Providing a Singapore Framework.

Authors:  Louis Tong; Li Lim; Donald Tan; Wee Jin Heng; Jimmy Lim; Cordelia Chan; Anshu Arundhati; Anna Tan
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2021-11-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.